CMS Open Payments · Program Year 2024
Bayer Healthcare LLC
Bayer Healthcare LLC reported $1,888,327.86 across General Payments, Research, and Ownership to 228 physicians and teaching hospitals across 249 transactions.
- $1.9M Top quartile payer
- All-tracks total
- 249 Above-median volume
- Transactions
- 228 Above-median reach
- Recipients
- −$108.4K
- General Payments vs PY2023
Bayer Healthcare LLC reported $1,888,327.86 across all CMS Open Payments tracks (General + Research + Ownership) to 228 physicians and teaching hospitals in Program Year 2024 - ranking #465 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $279,591.20, averaging $8.3K per recipient.
How Bayer Healthcare LLC's $1.9M all-tracks total breaks down
Bayer Healthcare LLC's payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
29/100
Total payments
F
27/100
Transaction volume
F
12/100
Physician reach
F
12/100
Payment type diversity
D
63/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer bayer-healthcare-llc Bayer Healthcare LLC
$1.9M · #465/1,925 · 0.0% industry · PY2024
- TOT $1.9M
- RANK #465
- SHARE 0.0%
- TXN 249
- RCP 228
- CAT 5
- GEN $279.6K
- ΔGEN −$108.4K
- TOP1 13.7%
- PY 2024
Volume peers
Nearest volume peer: Ares Trading SA ($1.9M)
Bayer Healthcare LLC sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Bayer Healthcare LLC's CMS-reported General Payments decreased by $108.4K (−27.9%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2023: BAYER HEALTHCARE LLCPY2024: Bayer Healthcare LLC. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $387,980.26
- PY2024
- $279,591.20
What the Data Shows for Bayer Healthcare LLC
The all-tracks total above combines three CMS reporting categories - General Payments, Research Payments, and Ownership/Investment interests - not one undifferentiated figure. For Bayer Healthcare LLC, that total blends General Payments (day-to-day consulting, meals, travel and speaking fees, shown separately above) with Research and Ownership/Investment interest records, each governed by its own CMS reporting rules. CMS publishes each Program Year's data roughly 12 months after the reporting period ends, so this reflects the most recently released cycle; see our methodology for how the tracks are standardized and compared across companies.
"Consulting Fee" leads the 5-category general-payment breakdown below at $225.0K (80.5% of General Payments, 53 transactions) - see our methodology for how research and ownership payments are reported separately.
General Payment Breakdown by Type
Bayer Healthcare LLC made 5 types of general payments. "Consulting Fee" is the largest category at $225.0K, 80.5% of General Payments.
Bayer Healthcare LLC reports 5 general-payment categories - the top three are Consulting Fee (80.5%), Compensation for Services Other Than Consulting (10.7%), and Travel and Lodging (7.4%). The remaining 2 categories make up 1.5% of this company's reported general-payment total. That multi-category mix is the kind of profile single-category reporters cannot show.
How Bayer Healthcare LLC divides its payments
Ranked by total dollars reported per category
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Consulting Fee | $225.0K | 53 | 80.5% |
| Compensation for Services Other Than Consulting | $29.9K | 3 | 10.7% |
| Travel and Lodging | $20.6K | 66 | 7.4% |
| Food and Beverage | $3.5K | 79 | 1.2% |
| Education | $675.00 | 27 | 0.2% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $115,367.58 (41.3%) of $279,591.20 in this company's General Payments records across 90 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Bayer Healthcare LLC
The five named recipients with the highest reported General Payments from this company
- 1
Andrea Leonard-Segal
$38,387.50 across 4 reported transactions
- 2
Yair Safriel
$35,819.37 across 18 reported transactions
- 3
Michael Blaha
$14,619.36 across 8 reported transactions
- 4
Joseph JAMES Cavallo
$13,638.20 across 14 reported transactions
- 5
Orest B Boyko
$12,903.15 across 12 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Bayer Healthcare LLC ranks #465 of 1,925 by total payments (top 24% by spend) but spreads that money notably more broadly than its spend rank alone would suggest -- #1,244 of 1,838 by HHI (bottom 32% least concentrated), a wider distribution than most similarly sized payers.
View all 12 companies in this HHI neighborhood as a list
- CONMED Corporation : $945.9K total payments, HHI 586
- Accuray Incorporated : $113.0K total payments, HHI 584
- IlluminOss Medical, Inc. : $168.9K total payments, HHI 583
- Medacta USA, Inc. : $8.4M total payments, HHI 583
- Kub Technologies Inc. : $14.7K total payments, HHI 583
- Acorda Therapeutics, Inc : $192.5K total payments, HHI 580
- Bayer Healthcare LLC (this company) : $279.6K total payments, HHI 578
- Nexxt Spine LLC : $292.8K total payments, HHI 576
- Solta Medical, a division of Bausch Health US, LLC : $585.9K total payments, HHI 572
- Bisco, Inc. : $180.9K total payments, HHI 571
- Gramercy Extremity Orthopedics LLC : $51.0K total payments, HHI 569
- LifeNet Health : $410.9K total payments, HHI 564
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Bayer Healthcare LLC's, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Bayer Healthcare LLC.
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Bayer Healthcare LLC.
Showing 6 of 1,924 companies with CMS-reported payment data.
QOL Medical, LLC
iRhythm Technologies, Inc.
Pharming Healthcare, Inc.
Lantheus Medical Imaging, Inc.
Milestone Scientific Inc.
Put this to use
Bayer Healthcare LLC ranks #465 of 1,925 by all-tracks total payments, led by "Consulting Fee".
- See where Bayer Healthcare LLC sits among every top spender on the full leaderboard. Top 100 by total payments
- Compare "Consulting Fee" spend across every manufacturer, not just Bayer Healthcare LLC. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.